J F Botet

1.9k total citations
23 papers, 1.4k citations indexed

About

J F Botet is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J F Botet has authored 23 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 10 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J F Botet's work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Colorectal Cancer Treatments and Studies (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). J F Botet is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Colorectal Cancer Treatments and Studies (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). J F Botet collaborates with scholars based in United States. J F Botet's co-authors include Charles J. Lightdale, Murray F. Brennan, Hans Gerdes, Carlos Urmacher, A G Zauber, Nancy E. Kemeny, David P. Kelsen, John Crown, S J Winawer and J. Joshua Smith and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

J F Botet

23 papers receiving 1.3k citations

Peers

J F Botet

PRM

SURGE

ONCOL

HEPAT

GASTR

A Tocchi Italy

Paolo Aurello Italy

Motonori Saku Japan

Francesco Stipa Italy

A Hill United Kingdom

Toshiki Matsubara Japan

Matsuo Nagata Japan

Yolanda Quijano Spain

Takuto Hikichi Japan

Hisashi Gunji Japan

A Tocchi Italy

J F Botet

774 ×1.0

PRM

1.2k ×1.7

SURGE

635 ×1.1

ONCOL

103 ×0.5

HEPAT

132 ×0.7

GASTR

Citations per year, relative to J F Botet J F Botet (= 1×) peers A Tocchi

Countries citing papers authored by J F Botet

Since Specialization

Citations

This map shows the geographic impact of J F Botet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J F Botet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J F Botet more than expected).

Fields of papers citing papers by J F Botet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J F Botet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J F Botet. The network helps show where J F Botet may publish in the future.

Co-authorship network of co-authors of J F Botet

This figure shows the co-authorship network connecting the top 25 collaborators of J F Botet. A scholar is included among the top collaborators of J F Botet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J F Botet. J F Botet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Charny, Caleb K., et al.. (1997). Clinical Observation: Congenital Absence of the Left Portal Vein in a Patient Undergoing Hepatic Resection. HPB Surgery. 10(5). 323–327. 11 indexed citations

Kelsen, David P., Martin S. Karpeh, Gary K. Schwartz, et al.. (1996). Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil.. Journal of Clinical Oncology. 14(6). 1818–1828. 97 indexed citations

Hann, Lucy E., Yuman Fong, J F Botet, et al.. (1996). Malignant hepatic hilar tumors: can ultrasonography be used as an alternative to angiography with CT arterial portography for determination of resectability?. Journal of Ultrasound in Medicine. 15(1). 37–45. 12 indexed citations

Kemeny, Nancy E., Jessica Conti, A Cohen, et al.. (1994). Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma.. Journal of Clinical Oncology. 12(11). 2288–2295. 127 indexed citations

Kemeny, Nancy E., A Cohen, Karen Seiter, et al.. (1993). Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer.. Journal of Clinical Oncology. 11(2). 330–335. 56 indexed citations

Smith, James W., Murray F. Brennan, J F Botet, Hans Gerdes, & Charles J. Lightdale. (1993). Preoperative endoscopic ultrasound can predict the risk of recurrence after operation for gastric carcinoma.. Journal of Clinical Oncology. 11(12). 2380–2385. 26 indexed citations

Lightdale, Charles J. & J F Botet. (1993). Staging of Esophageal Cancer. Endoscopy. 25(9). 655–659. 11 indexed citations

Kemeny, Nancy E., Jessica Conti, Karen Seiter, et al.. (1992). Biochemical modulation of bolus fluorouracil by PALA in patients with advanced colorectal cancer.. Journal of Clinical Oncology. 10(5). 747–752. 20 indexed citations

Botet, J F, Charles J. Lightdale, A G Zauber, et al.. (1991). Preoperative staging of esophageal cancer: comparison of endoscopic US and dynamic CT.. Radiology. 181(2). 419–425. 272 indexed citations

10.

Botet, J F & Charles J. Lightdale. (1991). Endoscopic sonography of the upper gastrointestinal tract.. American Journal of Roentgenology. 156(1). 63–68. 27 indexed citations

11.

Crown, John, E. S. Casper, J F Botet, P Murray, & David P. Kelsen. (1991). Lack of efficacy of high-dose leucovorin and fluorouracil in patients with advanced pancreatic adenocarcinoma.. Journal of Clinical Oncology. 9(9). 1682–1686. 100 indexed citations

12.

Crown, John, Ann A. Jakubowski, Nancy E. Kemeny, et al.. (1991). A phase I trial of recombinant human interleukin-1 beta alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer. Blood. 78(6). 1420–1427. 107 indexed citations

13.

Crown, John, Ann A. Jakubowski, N. E. Kemeny, et al.. (1991). A phase I trial of recombinant human interleukin-1 beta alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer. Blood. 78(6). 1420–1427. 4 indexed citations

14.

Botet, J F, Charles J. Lightdale, A G Zauber, et al.. (1991). Preoperative staging of gastric cancer: comparison of endoscopic US and dynamic CT.. Radiology. 181(2). 426–432. 220 indexed citations

15.

Kemeny, Nancy E., Donna Niedzwiecki, Douglass Chapman, et al.. (1990). Randomized study of continuous infusion fluorouracil versus fluorouracil plus cisplatin in patients with metastatic colorectal cancer.. Journal of Clinical Oncology. 8(2). 313–318. 85 indexed citations

16.

Kemeny, Nancy E., Donna Niedzwiecki, Bonnie Reichman, et al.. (1989). Cisplatin and 5-fluorouracil infusion for metastatic colorectal carcinoma. Differences in survival in two patient groups with similar response rates. Cancer. 63(6). 1065–1069. 11 indexed citations

17.

Dougherty, James, David P. Kelsen, Nancy E. Kemeny, et al.. (1989). Advanced Pancreatic Cancer: A Phase I-II Trial of Cisplatin, High-Dose Cytarabine, and Caffeine. JNCI Journal of the National Cancer Institute. 81(22). 1735–1738. 26 indexed citations

18.

Botet, J F, et al.. (1989). CT of primary lymphoma of the liver. American Journal of Roentgenology. 152(5). 973–976. 38 indexed citations

19.

Botet, J F, et al.. (1987). Bilateral perinephric abscesses: a complication of endoscopic injection sclerotherapy.. PubMed. 82(7). 670–3. 12 indexed citations

20.

Botet, J F, et al.. (1985). Cholangitis complicating intraarterial chemotherapy in liver metastasis.. Radiology. 156(2). 335–337. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact